Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
—1,101.371,103.631,105.311,091.41——
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
—613.35613.35613.35601.49——
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
—1,198.831,199.681,199.751,182.41——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
—1,755.951,754.061,756.031,734.69——
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
—638.51637.41637.41633.05——
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
—843.52843.35846.40837.93——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
—215.95215.95216.84215.06——
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
—3,138.913,189.303,230.853,174.76——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
—934.37934.72938.26927.50——
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
—1,477.431,474.121,474.121,451.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
—2,380.192,389.342,403.042,380.47——
SAN:EPA
Sanofi SA
€80.08
-2.05%
(-1.68) 1D
Apr 24, 5:38:52 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for SAN...
Open
€80.74
High
€81.64
Low
€80.08
Mkt. cap
96.92B
Avg. vol.
2.63M
Volume
2.69M
P/E ratio
19.87
52-wk high
€98.36
52-wk low
€74.85
EPS
€4.03
Shares outstanding
1.21B
No. of employees
75K
News stories
From sources across the web
Profile
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company’s seat in the Forbes Global 2000 was 89. Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
About Sanofi SA
CEOPaul Hudson
Employees74.8K
Founded1973
HeadquartersParis, Île-de-France, France
SectorPharmaceutical industry
Websitesanofi.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2026
Mar 2026
Jun 2026
Sep 2026
Revenue
11.24B
10.51B
-
-
Cost of goods sold
3.14B
-
-
-
Cost of revenue
3.14B
-
-
-
Research and development expenses
1.75B
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.33B
-
-
-
Operating expense
6.02B
-
-
-
Total operating expenses
9.16B
-
-
-
Operating income
2.09B
-
-
-
Other non operating income
60.00M
-
-
-
EBT including unusual items
2.01B
-
-
-
EBT excluding unusual items
1.98B
-
-
-
Income tax expense
420.00M
-
-
-
Effective tax rate
20.85%
-
-
-
Other operating expenses
1.41B
-
-
-
Net income
1.61B
-
-
-
Net profit margin
14.35%
-
-
-
Earnings per share
-
1.88
-
-
Interest and investment income
-
-
-
-
Interest expense
-178.00M
-
-
-
Net interest expenses
-178.00M
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
2.62B
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer